explained Professor Volker Lauschke, Principal Investigator of the study, Professor in Translational Pharmacology and Director of the Biofabrication and Tissue Engineering Facility at Karolinska Institute. “Differences between different 3D Cell Culture Plates can become significant however for specific applications.” Prof. Lauschke continued. “This is why validating different plates from different manufacturers before embarking on larger projects is advisable.”
96-well plates are predominantly used in academic research while industry often employs 384-well plates for advanced high-throughput screening. “Producing 384-well spheroid plates requires a more demanding technology.”, Prof. Lauschke continued, “Here the BIOFLOAT plates allow for increased reproducibility and are clearly leading the field.”
“We are very pleased about the results of the study”, Dr. Valentina Fermi, Director of Business Development at faCellitate, commented the published results. “The BIOFLOAT Technology has now proven to provide top performing results in the competitive area of 3D Cell Culture”.
The Publication can be download at http://dx.doi.org/10.1002/biot.202300587
About Karolinska Institute: Karolinska Institute is one of the world’s leading medical universities. It accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institute selects the Nobel laureates in Physiology or Medicine.
